Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 160.8 SEK -1.65% Market Closed
Market Cap: 12.8B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Interest Income Expense Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Interest Income Expense
-kr23m
CAGR 3-Years
-51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Interest Income Expense
-kr256m
CAGR 3-Years
-129%
CAGR 5-Years
-94%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Interest Income Expense
-kr227.9m
CAGR 3-Years
-363%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Interest Income Expense
-kr35k
CAGR 3-Years
59%
CAGR 5-Years
46%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Interest Income Expense
-kr6.8m
CAGR 3-Years
12%
CAGR 5-Years
5%
CAGR 10-Years
-27%
M
Magle Chemoswed Holding AB
STO:MAGLE
Interest Income Expense
-kr8.1m
CAGR 3-Years
-332%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biotage AB's Interest Income Expense?
Interest Income Expense
-23m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Interest Income Expense amounts to -23m SEK.

What is Biotage AB's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-51%

The average annual Interest Income Expense growth rates for Biotage AB have been -51% over the past three years .

Back to Top